Frailty Among Alzheimer’s Disease Patients

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|12|4|507-511

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.12, Iss.4, 2013-06, pp. : 507-511

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sundowning Syndrome: A Possible Marker of Frailty in Alzheimer’s Disease?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 4, 2013-01 ,pp. : 525-528

Bentham Science Publishers

Access to resources Recommend Favorite

Strength and Weaknesses of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease and Possible Detection of Overlaps with Frailty Process

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 4, 2013-06 ,pp. : 538-546

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer’s Disease

By  

Cells Tissues Organs, Vol. 162, Iss. 1, 1998-10 ,pp. : 46-55

Karger

Access to resources Recommend Favorite

Causes of Syncope in Patients with Alzheimer’s Disease Treated with Donepezil

By Bordier Philippe   Lanusse Stephane   Garrigue Stephane   Reynard Charlotte   Robert Frederic   Gencel Laurent   Lafitte Alexia  

Drugs & Aging, Vol. 22, Iss. 8, 2005-01 ,pp. : 687-694

Adis International

Access to resources Recommend Favorite

Risk of Antipsychotic Drug Use in Patients with Alzheimer’s Disease Treated with Rivastigmine

By Suh D-C.  

Drugs & Aging, Vol. 21, Iss. 6, 2004-01 ,pp. : 395-403

Adis International

Access to resources Recommend Favorite